Sigyn Therapeutics SIGY Cash Flow Statement (2016-2025)

OTC SIGY
$0.03 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Sigyn Therapeutics Quarterly Cash Flow Statement

Periods 37 quarters
Latest Sep 2025

Sigyn Therapeutics reported cash from operations of -$0.20M and free cash flow of -$0.20M for the quarter ended Sep 2025, down 21.7% year over year. This cash flow statement covers 37 quarters of results from Mar 2016 through Sep 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income
-0.45M-0.46M-0.65M-0.67M-1.23M-0.68M-0.67M-0.73M-0.86M-1.34M-0.72M-0.91M-1.18M-0.76M-0.86M-1.20M-0.52M-0.67M-1.45M-0.58M
Share-based CompensationStock Comp.
0.08M0.08M0.05M0.04M0.04M0.04M0.04M0.10M0.04M0.04M0.04M0.04M0.05M0.05M0.05M
Gains from Investment SecuritiesGains Investment
-0.02M-0.21M-0.00M-0.13M0.02M-0.06M0.02M
Cash from OperationsCash from Ops.
-0.28M-0.27M-0.41M-0.54M-0.55M-0.46M-0.39M-0.52M-0.45M-0.56M-0.33M-0.36M-0.13M-0.24M-0.18M-0.16M-0.29M-0.29M-0.15M-0.20M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.01M0.01M0.00M899.00900.00900.00900.00900.00900.00900.00900.00300.00
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
Change in Account PayablesChange Payables
0.01M0.03M-0.00M-0.01M0.01M0.16M0.10M0.01M0.02M-0.06M0.07M0.02M0.16M0.07M-0.04M0.12M-0.00M0.06M0.06M0.04M
Change in Accured ExpensesChange Accured Exp.
-0.19M0.00M-636.000.04M-0.02M789.00534.00-640.00555.00-0.00M339.00-0.00M-0.00M-0.00M90.00-0.00M0.00M524.00
Change in TaxesChange Taxes
0.04M0.01M13.00-0.02M-0.04M-0.04M0.01M0.15M0.22M0.32M0.29M0.42M0.27M0.11M0.14M0.18M0.09M
Other Working Capital ChangesOther WC Changes
139.00-0.03M0.01M0.04M-0.04M0.00M0.03M0.02M-875.000.00M-0.00M-0.01M0.01M-0.05M-0.00M-0.00M-0.00M
Investing Activities
Capital ExpendituresCapex
0.00M0.02M0.01M1.00
Divestments
Cash from Investing ActivitiesCash from Investing
-0.00M-0.02M-0.01M-1.00
Financing Activities
Cash from Financing ActivitiesCash from Financing
10.000.20M1.46M0.40M0.20M0.32M0.55M0.43M0.88M0.03M0.41M0.07M0.26M0.20M0.27M0.14M0.30M0.14M0.28M
Additional items
Change in Cash
-0.28M-0.08M1.05M-0.56M-0.16M-0.26M-0.07M0.02M-0.02M0.31M-0.30M0.04M-0.05M0.02M0.02M0.11M-0.15M751.00-0.01M0.09M
Free Cash FlowFCF
-0.28M-0.28M-0.41M-0.56M-0.56M-0.46M-0.39M-0.52M-0.45M-0.56M-0.33M-0.36M-0.13M-0.24M-0.18M-0.16M-0.29M-0.29M-0.15M-0.20M
Net Cash FlowNCF
-0.28M-0.08M1.05M-0.56M-0.16M-0.26M-0.07M0.02M-0.02M0.31M-0.30M0.04M-0.05M0.02M0.02M0.11M-0.15M751.00-0.01M0.09M